GP73 overexpression has been identified in various acute and chronic liver diseases [14], [18]–[20], and serum GP73 is considered as a better biomarker in the early diagnosis of liver diseases than the conventional alpha-fetoprotein [21]–[24]. The gene discussed is GOLM1; the disease is liver disorder.